不同剂量阿托伐他汀钙治疗急性脑梗死的疗效及其相关因素的影响
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:

陕西省自然科学基金


Effect of different doses of atorvastatin calcium in treatment of acute cerebral infarction and its effect on carotid atherosclerotic plaque and vascular endothelial function
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    【摘要】 目的 探讨不同剂量阿托伐他汀钙治疗急性脑梗死的疗效及对颈动脉粥样硬化斑块与血管内皮功能的影响。 方法 选择2015年2月~2017年8月我院接诊的96例急性脑梗死患者,通过随机数表法分为A组(48例)和B组(48例),在常规对症治疗基础上,两组均使用阿托伐他汀治疗,A组剂量10mg/次·d,B组剂量20mg/次·d,均连续治疗3个月。比较两组临床疗效、血脂、颈动脉内膜及中膜厚度(IMT)、斑块面积、血管内皮功能、美国国立卫生研究院卒中量表(NIHSS)评分及不良反应。结果 治疗后,B组总有效率明显高于A组(P<005),两组血清总胆固醇(TC)、三酰甘油(TG)、低密度脂蛋白(LDLC)较治疗前均显著降低(P<005),高密度脂蛋白胆固醇(HDLC)明显升高(P<005),B组TC、TG、LDLC明显低于A组,HDLC明显比A组高(P<005),两组颈动脉IMT、斑块面积较治疗前均显著缩小(P<005),B组颈动脉IMT、斑块面积明显小于A组(P<005);两组一氧化氮(NO)、血管舒张功能(FMD)较治疗前均显著增加(P<005),内皮素(ET1)显著降低(P<005),B组NO、FMD明显高于A组(P<005),ET1明显比B组低(P<005);两组NIHSS评分较治疗前均显著降低(P<005),B组NIHSS评分明显低于A组(P<005);两组不良反应发生率比较差异无统计学意义(P>005)。结论 在急性脑梗死患者中使用大剂量(20mg/次·d)的阿托伐他汀钙效果更加显著,可有效改善患者血脂、颈动脉粥样硬化斑块、血管内皮功能及神经功能,且不增加药物不良反应,可供临床参考。

    Abstract:

    【Abstract】 Objective To study effect of different doses of atorvastatin calcium in treatment of acute cerebral infarction and its effect on carotid atherosclerotic plaque and vascular endothelial function. Methods 96 patients of acute cerebral infarction received therapy from February 2015 to August 2017 in our hospital were selected as research objects. According to random number table, those patients were divided into the A group (n=48) and the control group (n=48). On the basis of routine symptomatic treatment, they were treated with atorvastatin, the dose of A group was 10mg/times/d, the dose of A group was 10mg/ times/d for 3 months. The clinical efficacy, blood lipid, carotid intima media thickness (IMT), plaque area, vascular endothelial function, National Institutes of Health Stroke Scale (NIHSS) score and adverse reactions were compared between the two groups. Results After treatment, the total effective rate of group B was 9375%, which was significantly higher than that of A group(P<005). After treatment, the serum total cholesterol (TC), three acylglycerol (TG) and low density lipoprotein (LDLC) in the two groups were significantly lower than those before treatment, and the highdensity lipoprotein cholesterol (HDLC) increased significantly(P<005). The TC, TG and LDLC in group B were significantly lower than that of A group, and HDLC was significantly higher than that of A group(P<005). After treatment, the carotid artery IMT and plaque area in the two groups were significantly reduced (P<005). The carotid artery IMT and plaque area in B group was less than that of A group (P<005). After treatment, the nitric oxide (NO) and vasodilatation (FMD) in the two groups were significantly increased, and the endothelin (ET) 1 decreased significantly (P<005). The NO and FMD in B group were higher than that of A group. The ET1 in B group was lower than that of A group(P<005). After treatment, the NIHSS scores in the two groups were significantly reduced (P<005), and the NIHSS score in group B was significantly lower than that in the A group (P<005). There was no significant difference in the incidence of adverse reactions between the two groups(P>005). Conclusion Atorvastatin with large dose (20mg/times/d) is effective for acute cerebral infarction, which can effectively improve blood lipids, carotid atherosclerotic plaques, vascular endothelial function and neurological function, and does not increase adverse drug reactions, so it has high clinical application value.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2018-06-28
您是第位访问者
网站版权所有:《西部医学》编辑部     蜀ICP备18038379号-4
地址:四川省成都市武侯区小天竺街75号财富国际18F-1号    邮政编码:610041
电话:028-85570072/85588403 本网站支持 IPv6    E-mail:xbyxqk@163.com
技术支持:北京勤云科技发展有限公司